SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-20-012388
Filing Date
2020-08-11
Accepted
2020-08-11 06:26:36
Documents
69
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q surf-20200630.htm   iXBRL 10-Q 1697897
2 EX-31.1 surf-06302020xexx311.htm EX-31.1 11441
3 EX-31.2 surf-06302020xexx312.htm EX-31.2 11628
4 EX-32.1 surf-06302020xexx321.htm EX-32.1 5730
5 EX-32.2 surf-06302020xexx322.htm EX-32.2 5745
  Complete submission text file 0001628280-20-012388.txt   7254299

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT surf-20200630.xsd EX-101.SCH 42492
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT surf-20200630_cal.xml EX-101.CAL 74315
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT surf-20200630_def.xml EX-101.DEF 257544
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT surf-20200630_lab.xml EX-101.LAB 593477
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT surf-20200630_pre.xml EX-101.PRE 392262
11 EXTRACTED XBRL INSTANCE DOCUMENT surf-20200630_htm.xml XML 1299353
Mailing Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139 617-714-4096
Surface Oncology, Inc. (Filer) CIK: 0001718108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38459 | Film No.: 201091007
SIC: 2836 Biological Products, (No Diagnostic Substances)